Nix

Boston, United States Founded: 2015 • Age: 11 yrs
Sweat-based biosensors are provided for body hydration monitoring.

About Nix

Nix is a Healthcare company based in Boston (United States) founded in 2015. It operates as a sweat-based biosensors are provided for body hydration monitoring. It operates in the Healthcare, Consumer, and Technology sectors. Nix has raised $16.95 million across 12 funding rounds from investors including Techstars, Black Lab Sports and Stadia Ventures. Its website nixbiosensors.com draws about 21 thousand monthly visits. Its focus areas include HealthTech, Disease Self Management, Body Health Parameters and Monitoring. Its competitors include Athos, Epicore Biosystems, Cardea Bio, Hememics Biotechnologies and MYZONE and 4 more; 9 of its 9 listed competitors have raised funding.

Company details

Nix was established in 2015 in Boston, United States, as a provider in the health technology sector. Sweat-based biosensors are developed for tracking hydration levels through a dedicated platform. Single-use wearable devices are offered, incorporating stimuli-responsive hydrogels and nanoscale photonic structures. These components generate analogue optical signals in response to micro-environmental changes, supporting user monitoring of physiological states. Operations focus on biosensor innovation for practical applications.

  • Headquarters Boston, United States
  • Sectors
    Healthcare
    Consumer Technology Media & Entertainment
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website nixbiosensors.com
  • Social LinkedIn X Facebook
Key Metrics
  • Total Equity Funding
    $16.95M (USD)

    in 12 rounds

  • Latest Funding Round
    $10M (USD), Series A

    Sep 2026

  • Investors
    Techstars

    & 5 more

Funding Insights of Nix

Nix has successfully raised a total of $16.95M across 12 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in September 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $16.95M
  • Total Rounds 12
  • Last Round Series A β€” $10M
  • Investors Count 6

Latest 10 of 12 funding rounds of Nix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2026$10MSeries A––
Dec 2022$2.75MSeries A––
–
May 2022$1.5MSeed––
–
May 2021$800,000Seed––
–
Apr 2019$150,000Seed––
–
Apr 2019–Debt – Conventional––
–
Oct 2018$15,000Grant––
Jun 2017$120,000Seed–Techstars
–
Nov 2016$615,000Seed––
–
Sep 2016–Seed–Stadia Ventures
–
Valuation history

6 investors in total: 6 institutional.

Investors in Nix

Nix has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Techstars, Black Lab Sports and Stadia Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Black Lab Sports is operated as a center for human performance.
–blacklabsports.comBoulder, United States
Startups are accelerated globally without sector restrictions through structured programs.
2006techstars.comNew York, United States
Sports sector startups are accelerated through a focused program.
–stadiaventures.comSt. Louis, United States
-
–shorewindcapital.com-
-
–greatoaksvc.com-
-
–whiteroadinvestments.com-
Premium access

Investor details for Nix

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Nix

21 people are tracked at Nix (4 in leadership, 15 in board & advisors, 2 in team).

NameRoleGroup
Meridith Cass
CEOLeadership
Morgan Rosin
VP, eCommerceLeadership
Tim Hadzima
Vice President, Global PartnershipsLeadership
David Renton
Interim CTOLeadership
Tatyana McFadden
Sports AdvisorBoard & advisors
Brad Wilkins
Scientific AdvisorBoard & advisors
Dean Karnazes
Sports AdvisorBoard & advisors
Dave Mcgillivray
Business AdvisorBoard & advisors
Stephanie Connaughton
Business AdvisorBoard & advisors
Peter Gladstone
Business AdvisorBoard & advisors
Bob Murray
Scientific AdvisorBoard & advisors
Eric Boutin
Business AdvisorBoard & advisors
Doug Ziewacz
Business AdvisorBoard & advisors
Magdalena Boulet
Business AdvisorBoard & advisors
Brandon Janosky
Business AdvisorBoard & advisors
Shalane Flanagan
Sports AdvisorBoard & advisors
Doug Casa
Scientific AdvisorBoard & advisors
Ian Fitzpatrick
Business AdvisorBoard & advisors
Tom Fowler
Business AdvisorBoard & advisors
Sasang Balachandran
Senior Software DeveloperTeam

1 more people are available in the full profile.

Premium access

Complete people profiles for Nix

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Nix

3 dated milestones of Nix across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Nix is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A, of $10.0M.

Competitors of Nix

Nix has 9 listed competitors in our database, 9 of them funded. They include Athos, Epicore Biosystems, Cardea Bio, Hememics Biotechnologies and MYZONE, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
liveathos.com2012Redwood, United States$51.2M33
Wearable technology is integrated into smart workout clothing by Athos.
epicorebiosystems.com2017Cambridge, United States$43.89M–
Wearable sweat-based microfluidic sensing systems are provided for health monitoring.
cardeabio.com2019San Diego, United States$21.8M–
Digital graphene biosensors are developed using machine learning.
hememics.com2009Gaithersburg, United States$4.6M13
Biopreservation platform for mammalian cells and biologics is developed.
myzone.org2011Douglas, United Kingdom$17.2M39
Developer of a wearable heart rate monitoring system
alignedbio.com2019Lund, Sweden$908,526–
Nanowire-based sensors and alignment technologies are provided for molecular detection.
monod.bio2021Seattle, United States$25M–
Developer of biosensors to detect viral proteins, toxins, antibodies, and other molecules
myolaris.com2014Waltham, United States$62,5009
In-vitro diagnostics are developed for oncology, transplants, and neurodegeneration.
crystaldiagnostics.com1965Broomfield, United States$2M38
Patented biosensors for detecting pathogens in food produce are developed.
Premium access

Detailed competitors of Nix

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Nix

The website of Nix (nixbiosensors.com) receives about 21.4K visits a month.

  • Monthly visits
    21.4K

    ▲ 33% vs previous month

Similar websites

Websites whose visitors overlap most with Nix. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lifesignals.com
100%
4.8K#4,376,480View details
nixlice.com
nixlice.com
77%
–#857,428–
hdroptech.com
47%
4.9K#4,076,958View details

Top companies in Life Sciences Platforms & Tools

10 companies that operate in the same segment as Nix (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B–1,111
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Nix

Premium access

Complete news archive for Nix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nix

Nix was founded in 2015.

Nix is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.

Nix is a funded company, having raised a total of $16.95M across 12 funding rounds to date.

Nix was established in 2015 in Boston, United States, as a provider in the health technology sector. Sweat-based biosensors are developed for tracking hydration levels through a dedicated platform. Single-use wearable devices are offered, incorporating stimuli-responsive hydrogels and nanoscale photonic structures. These components generate analogue optical signals in response to micro-environmental changes, supporting user monitoring of physiological states. Operations focus on biosensor innovation for practical applications.

Nix's top competitors include Epicore Biosystems, Olaris and Athos.

Nix has 6 investors. Key investors include Techstars, Black Lab Sports, Stadia Ventures, Shorewind Capital, and Great Oaks Venture Capital.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available